Sep 2026· American Journal of Pathology· Vol 196, pp. 2488-2506· 0 citations· 50 references
Medicine
TL;DR
A novel mechanism linking aerobic exercise to atherosclerosis via EV-miRNAs is highlighted, proposing potential therapeutic strategies for atherosclerosis based on exercise-induced circulating EVs-miR-203a-3p and miR-133b-3p.
Abstract
Aerobic exercise reduces cardiovascular disease risk, with atherosclerosis being a primary contributor. While circulating extracellular vesicles (EVs) mediate intercellular communication, their role in this process remains unclear. This study aimed to investigate the role of aerobic exercise-derived circulating EVs in mitigating macrophage inflammation and lipid accumulation in an atherosclerotic model. Circulating EVs were isolated from the plasma of exercise-trained and sedentary mice. miRNA profiling of EVs was performed using miRNA arrays and quantitative real-time PCR. Aortic atherosclerosis was assessed by Oil Red O staining, immunofluorescence, and ELISA. Functional validation of EV effects was carried out through EVs labeling, cell transfection, luciferase reporter assays, and flow cytometry. Aerobic exercise slowed the progression of atherosclerosis and altered the miRNA profile of circulating EVs, notably increasing miR-203a-3p and miR-133b-3p expression. EVs from exercise-trained mice inhibited macrophage-driven inflammation and lipid accumulation in vitro and in vivo. Treatment with miR-203a-3p and miR-133b-3p mimics reproduced the anti-atherosclerotic effects, while inhibitors of these miRNAs reversed the effects. Mechanistically, miR-203a-3p and miR-133b-3p reduced macrophage inflammation and lipid accumulation by targeting Tlr4 and Insr, respectively, thereby suppressing NF-κB/NLRP3 signaling. Notably, the increased expression of miR-203a-3p and miR-133b-3p was primarily derived from skeletal muscle. These findings highlight a novel mechanism linking aerobic exercise to atherosclerosis via EV-miRNAs, proposing potential therapeutic strategies for atherosclerosis based on exercise-induced circulating EVs-miR-203a-3p and miR-133b-3p.
Introduction Dysregulated lipid metabolism and inflammation are two core pathological drivers of atherosclerosis; however, their causal interplay remains incompletely elucidated. Macrophages play a central role in sustaining unresolved inflammation, which is a hallmark of atherosclerosis. Recent single-cell RNA-sequenc...
Mao-Zhuo Lan, Yang-Yang Zhou, Yue Sun et al.· Frontiers in Cardiovascular...· 0 citations
AIMS
Atherosclerosis (AS) is a chronic inflammatory disease driven by complex cellular crosstalk within plaques. How a key inflammatory pathway orchestrates multicellular vascular injury and whether this is conserved across vascular beds remains incompletely understood.
METHODS
Carotid and coronary plaques were profi...
Tao Wang, Chang-Tian Hu, Heng-Lei Xia et al.· Atherosclerosis· 0 citations
Plaque erosion is increasingly recognized as a critical pathological mechanism in acute coronary syndrome. In this study, we found that microRNA-145 (miR-145) levels were significantly reduced in plaques with grade III-IV stenosis compared with controls. Using an apoE-/- mouse model fed a high-cholesterol diet, we demo...
Yun-Juan Jiao, Gao-En Ma, Jun-Kai Ma et al.· Biochimica et Biophysica Act...· 0 citations
BACKGROUND
Aging and obesity synergistically promote pathological vascular remodeling mediated by endothelial-mesenchymal transition (EndMT). Fatty acid-binding protein 3 (FABP3) maintains fatty acid homeostasis and cardiovascular function; however, its role in EndMT-driven vascular remodeling under combined aging and...
Wen-Jing Chen, Dong-Ying Lv, Yu-Jie Ren et al.· International Immunopharmaco...· 0 citations
BACKGROUND
Atherosclerosis is a chronic vascular disease characterized by endothelial dysfunction and lipid accumulation. Ferroptosis, an iron-dependent form of regulated cell death characterized by excessive lipid peroxidation, plays a pivotal role in endothelial injury and the progression of atherosclerosis. Fibrobla...
Dan-Dan Song, Zhen-Zhen Chen, Chao Qi et al.· International Immunopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.